By reducing the colonic activation of NF-κB (Figure 6), it is possible that BC-30 treatment improved the barrier function of the colonic mucosa (Figure 5C), thereby improving stool consistency (Figures 2 and 3). This evidence concerns the gene NFKB1 and breast cancer.